Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16137 articles
Nano-silymarin combined with methylene blue photodynamic therapy versus monotherapies of head and neck squamous cell carcinoma: in-vitro study
Nano-silymarin significantly potentiates anticancer efficacy of MB-PDT.
»
06/29/26
CD44 expression associates with EBV LMP1, reduced CD8⁺ T cell infiltration, and lower PD-L1 combined positive score in nasopharyngeal carcinoma
TfR1 expression associated with advanced tumor stage.
»
06/29/26
A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunction
Continuous sarcopenia probability score correlated with muscle mass.
»
06/29/26
Optimized chemotherapy sequence for metastatic pancreatic ductal adenocarcinoma patients: FOLFIRINOX followed by Gemcitabine plus nab-paclitaxel
GEM-NABP outperformed FOLFOX6.
»
06/30/26
IL-17-driven tumor cell–intrinsic inflammatory programming creates an immunotherapy-permissive microenvironment
IL-17 directly activated NF-κB–dependent inflammatory programs in OCCC tumor cells.
»
06/30/26
Comprehensive CYP2D6 genotyping improves phenotype classification and highlights methodological pitfalls in tamoxifen-treated breast cancer
Comprehensive CYP2D6 profiling improves phenotype assignment.
»
07/01/26
Single-session agreement of ChatGPT and Gemini treatment recommendations with multidisciplinary tumor board decisions in thoracic oncology
Initial outputs of ChatGPT and Gemini showed moderate agreement with MDTB decisions.
»
07/02/26
Limb-bud and heart (LBH) promotes expansion and survival of esophageal adenocarcinoma cells
LBH expression significantly elevated in EAC tissues and cell lines.
»
07/02/26
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm
Glofitamab significantly improved RMST of 5 months.
»
07/01/26
KRAS inhibition is an effective therapy for appendiceal adenocarcinoma
KRAS inhibition can activate innate immune response in setting of peritoneal metastases.
»
07/02/26
< Prev
Next >